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ABSTRACT The suprachiasmatic nucleus governs daily variations of physiology and behavior in mammals. Within single
neurons, interlocked transcriptional/translational feedback loops generate circadian rhythms on the molecular level. We present
a mathematical model that reﬂects the essential features of the mammalian circadian oscillator to characterize the differential
roles of negative and positive feedback loops. The oscillations that are obtained have a 24-h period and are robust toward
parameter variations even when the positive feedback is replaced by a constantly expressed activator. This demonstrates the
crucial role of the negative feedback for rhythm generation. Moreover, it explains the rhythmic phenotype of Rev-erba/ mutant
mice, where a positive feedback is missing. The interplay of negative and positive feedback reveals a complex dynamics. In
particular, the model explains the unexpected rescue of circadian oscillations in Per2Brdm1/Cry2/ double-mutant mice
(Per2Brdm1 single-mutant mice are arrhythmic). Here, a decrease of positive feedback strength associated with mutating the
Per2 gene is compensated by the Cry2/ mutation that simultaneously decreases the negative feedback strength. Finally, this
model leads us to a testable prediction of a molecular and behavioral phenotype: circadian oscillations should be rescued when
arrhythmic Per2Brdm1 mutant mice are crossed with Rev- erba / mutant mice.
INTRODUCTION
Most organisms have developed endogenous circadian clocks
to anticipate daily variations in their environment. In mam-
mals, the master circadian clock is located in the supra-
chiasmatic nucleus of the hypothalamus, where it orchestrates
diurnal changes in physiology and behavior. Circadian oscil-
lations, which have a period of ;24 h, are generated within
single neurons by interlocked transcriptional/translational
feedback loops (for a review, see Reppert andWeaver, 2002).
In a negative feedback loop, transcription of the period and
cryptochrome genes (Per1,Per2,Cry1, andCry2) is activated
by the transcription factor heterodimer BMAL1/CLOCK.
After several hours, PER and CRY proteins downregulate
their own synthesis by inhibiting BMAL1/CLOCK. Conse-
quently, PER and CRY levels fall, thus, BMAL1/CLOCK is
no longer inhibited and restarts the cycle. In a positive
feedback loop, Bmal1 mRNA oscillations are caused by the
rhythmic inhibition of Bmal1 transcription by REV-ERBa.
Rev-erba is presumably also activated by BMAL1/CLOCK
and inhibited by PERs and CRYs. Thus, Bmal1 transcription
is essentially positively regulated by PERs andCRYs (Fig. 1).
Experiments in circadian systems of Neurospora, Dro-
sophila, and mammals as well as theoretical studies
underline the importance of a delayed negative feedback
for the generation of oscillations (Glass and Mackey, 1988).
The function of the positive feedback in the circadian
clock, however, is much less understood. Interlocked
feedback loops potentially allow for multiple inputs and
outputs at different phases (Allada, 2003). A contribution of
the positive feedback to the robustness of the clock has been
deduced from a study with Rev-erba/mutant mice, whose
clocks essentially lack the positive feedback (Preitner et al.,
2002), and from a study in the Neurospora circadian system
(Cheng et al., 2001).
Mathematical models provide insight into properties of
the circadian oscillators (Ruoff and Rensing, 1996; Scheper
et al., 1999; Smolen et al., 2004; Tyson et al., 1999; Ueda
et al., 2001; for a review, see Goldbeter, 2002). In two
models (Smolen et al., 2002, 2004) the role of the positive
feedback in the Drosophila clock has been discussed. Re-
cently, models of the circadian oscillator were published
describing the molecular processes in great detail (Forger
and Peskin, 2003; Leloup and Goldbeter, 2003), however,
without focusing on the speciﬁc function of the positive
feedback.
We propose a model for the mammalian circadian
oscillator designed for investigating the interdependence of
the positive and negative feedback. A reduced but essential
set of variables is used to analyze the impact of these feed-
back loops on the oscillation dynamics. Our model shows
sustained oscillations with period and phases in agreement
with experimental observations. With and without positive
feedback the period, phase, and amplitudes of the oscil-
lations are quite robust in response to varying single param-
eters. The simultaneous regulation of the two interlocked
feedback loops contributes to the maintenance of oscillations
and the stability of the period. Using this model, we propose
an explanation for the unexpected phenotype of the
Per2Brdm1/Cry2/ double-mutant mice (Oster et al.,
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2002). In addition, we predict the yet unknown phenotype of
the Per2Brdm1/Rev-erba/ double-mutant mice to be
rhythmic.
Model assumptions
Here, we describe a model of the mammalian circadian core
oscillator using a system of ordinary differential equations.
The variables of the system represent the concentrations of
clock genes’ mRNAs and proteins (Fig. 2). We focus spe-
ciﬁcally on the essential structure of the molecular network
to characterize the role of the positive and negative feedback
loops.
Clock components oscillate with a period close to 24 h.
The delay, which is necessary for oscillations in negative
feedback loops (Friesen and Block, 1984; Glass and
Mackey, 1988), is caused by processes including post-
translational modiﬁcation, degradation, complex formation
as well as nuclear import and export (Reppert and Weaver,
2002). The transcription factors CLOCK and BMAL1
activate as a heterodimer the transcription of Per, Cry, and
Rev-erba genes. For our model, we only consider the acti-
vation by BMAL1, because CLOCK is expressed at a
constant level (Maywood et al., 2003) and thus is equivalent
to a ﬁxed parameter. PER and CRY proteins downregulate
their own synthesis by inhibiting BMAL1/CLOCK trans-
activation activity. Cry genes are essential components of the
clock network, because null mutations in these genes disrupt
oscillations (Cry1//Cry2/ double-mutant mice) or alter
their period (Cry1/ or Cry2/ single-mutant mice) (van
der Horst et al., 1999; Vitaterna et al., 1999). As little is
known about the differential functions of the CRY proteins,
they are represented by a combined variable in the model. In
the case of Per genes we only include Per2, because a null
mutation in the Per2 gene causes arrhythmicity (Zheng et al.,
2001), whereas different phenotypes have been reported for
three Per1/ mutant mouse strains (Bae et al., 2001;
Cermakian et al., 2001; Zheng et al., 2001). However, in
principle Per1 could be included into the model (see
Discussion). Besides being an inhibitor of BMAL1/CLOCK,
PER2 is thought to act positively on Bmal1 transcription
(Shearman et al., 2000b). Per2 and CrymRNAs and proteins
are represented by the same variables, respectively, for the
FIGURE 2 Model of the mammalian circadian core oscillator. An
activated form of BMAL1 (BMAL1*) activates the transcription of Per2
and Cry genes resulting in an increase of Per2/CrymRNA (y1). As the levels
of PER2 and CRY proteins increase, they form a complex (y2), which is
transported to the nucleus. The nuclear PER2/CRY complex (y3) inhibits
Per2/Cry transcription and activates Bmal1 transcription. As a result, Bmal1
mRNA (y4) and protein (y5) increase. Nuclear BMAL1 (y6) in its active
form (BMAL1*, y7) restarts transcription of Per2 and Cry genes. Dashed
arrows represent degradation of mRNAs and proteins. Reference parameters
of the reaction kinetics are given in Table 1.
FIGURE 1 Schematic view of the mammalian circadian core oscillator
(modiﬁed from Reppert and Weaver, 2002). The clock mechanism
comprises interlocked positive (green) and negative (red) feedback loops.
The heterodimer BMAL1/CLOCK (C and B; green ovals) activates
transcription of Per, Cry, and Rev-erba genes. PER proteins (P; red
square) are phosphorylated (d) and form a complex with CRY proteins (C;
red diamond) and CKIe/d (e/d; red circle). In the nucleus this complex
inhibits the transactivational activity of BMAL1/CLOCK, thus forming the
negative feedback loop. In the positive feedback loop, Bmal1 transcription is
activated (derepressed) by PER/CRY/CKIe/d, because this complex also
inhibits REV-ERBa synthesis (R, green square), which on its part represses
Bmal1 transcription. The action of kinases (?) other than CKIe and CKId is
likely (Sanada et al., 2002).
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following reasons: i), their expression is coregulated by
BMAL1/CLOCK; ii), they form a complex that is necessary
for nuclear accumulation (Kume et al., 1999); iii), they are
both targets of casein kinase Ie/d (CKId/e) (Toh et al., 2001;
Eide et al., 2002); iv), the phase of their nuclear accumu-
lation is similar (Reppert and Weaver, 2002); v), they both
act negatively on BMAL1/CLOCK transactivational activity
in vitro (Jin et al., 1999; Shearman et al., 2000b); and vi),
details about the exact differential function of Cry and Per
genes in the core oscillator are not known.
CKIe is considered implicitly by assuming fast phosphor-
ylation of PER2 and CRY. This assumption and a rapid
degradation of the monomeric proteins (Akashi et al., 2002;
Shearman et al., 2000b) lead to a quasisteady state of the
monomeric PER2 and CRY proteins. Here, we assume the
same kinetics for PER2 and CRY, as no data exist regarding
the stability of monomeric CRY. As a consequence, it is not
necessary to consider the monomeric proteins as a separate
variable in the model (for a detailed calculation see Supple-
mentary Material). The PER2/CRY complex in the nucleus
inhibits BMAL1/CLOCK activation of Per, Cry, and Rev-
erba genes. REV-ERBa has been described to repress
Bmal1 transcription (Preitner et al., 2002; Ueda et al., 2002).
In the end, this double-negative loop constitutes a positive
feedback loop. In our model, REV-ERBa is implicitly taken
into account by assuming a positive action of the PER2/CRY
complex on Bmal1 transcription. In the model (Fig. 2), the
variable y1 represents the concentration of Per2 or Cry
mRNA, which are considered to be identical. y2 and y3 rep-
resent the concentrations of the PER2/CRY complex in the
cytoplasm and the PER2/CRY complex in the nucleus,
respectively. The variable y4 represents the concentration
of Bmal1 mRNA, y5 of cytoplasmatic BMAL1 protein, and
y6 of BMAL1 protein in the nucleus. The variable y7
describes the concentration of a transcriptionally active
form BMAL1*, which can be understood as a complex with
CLOCK (Gekakis et al., 1998) and/or as a phosphorylated
form of BMAL1 (Eide et al., 2002).
The dynamics of these variables is described by the
following system of differential equations:
dy1
dt
¼ f ðtransPer2=CryÞ  k1d  y1 (1)
dy2
dt
¼ k2b  y1q  k2d  y2 k2t  y21 k3t  y3 (2)
dy3
dt
¼ k2t  y2 k3t  y3 k3d  y3 (3)
dy4
dt
¼ f ðtransBmal1Þ  k4d  y4 (4)
dy5
dt
¼ k5b  y4 k5d  y5 k5t  y51 k6t  y6 (5)
dy6
dt
¼ k5t  y5 k6t  y6 k6d  y61 k7a  y7  k6a  y6 (6)
dy7
dt
¼ k6a  y6 k7a  y7  k7d  y7: (7)
Both transcription rates, f(transPer2/Cry) and f(transBmal1),
are described by Hill functions implying switch-like
behavior of the transcriptional effectors (Yuh et al., 1998)
and saturation of transcriptional activity.
The rate of Per2/Cry transcription f(transPer2/Cry)
f ðtransPer2=CryÞ ¼ v1b  ðy71 cÞ
k1b  ð11 ðy3=k1iÞpÞ1 ðy71 cÞ; (8)
increases with rising BMAL1* concentration (y7) and with
decreasing nuclear PER2/CRYconcentration (y3). More-
over, a constitutive transcriptional activator of Per2/Cry
transcription is included in the transcription term by the
parameter c. This term is a phenomenological representation
of the switch-like behavior of this transcriptional regulation
rather than a precise description of molecular processes.
The transcription rate of Bmal1 f(transBmal1) is given by:
f ðtransBmal1Þ ¼ v4b  y3
r
k
r
4b1 y3
r: (9)
It increases with rising PER2/CRY concentration (y3).
We use linear and bilinear kinetics for the description of
translation, degradation, complex formation, transport across
the nuclear membrane, and posttranslational modiﬁcation, as
the molecular details of these processes are not fully char-
acterized. A description of the corresponding parameters is
given in Table 1.
In negative feedback loops, high Hill coefﬁcients, an
explicit delay or Michaelis Menten kinetics can reduce the
number of reaction steps that are needed to obtain oscil-
lations. For the purpose of this model, we chose to use a small
system based on linear kinetics and with a high Hill
coefﬁcient, as this keeps the number of parameters in the
system low. This implies a strong nonlinearity of the reg-
ulation of Per2/Cry transcription. Indeed, Etchegaray et al.
(2003) have recently found that the regulation of CLOCK/
BMAL1 activity by CRY proteins is likely to be modulated
by histone acetylation and chromatin remodeling in the
promoter regions of circadian genes. Multiple histone acet-
ylation events, or other chromatin modiﬁcations could con-
tribute to the kinetic nonlinearity, which we modeled by
using high Hill coefﬁcients in Eqs. 8 and 9.
The system of differential equations was solved numer-
ically by using a Runge-Kutta algorithm. For the comparison
with experimental data and the analysis of robustness the
model was implemented in MATLAB (The MathWorks,
Natick, MA), the bifurcation analysis was performed with
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XPP/AUTO (G. Bard Ermentrout; http://www.pitt.edu/
phase/).
RESULTS
Dynamics of the model: comparison with
experimental observations
For a model of the circadian oscillator, the consistency of its
dynamical behavior with experimental observations is a
prerequisite for further investigations. Using parameters
within a biologically plausible range (Hargrove et al., 1991;
Wagner et al., 1990) we were able to reproduce experimen-
tally observed circadian oscillations. Due to their relatively
small number the parameters could be optimized by trial and
error. Criteria for parameter estimations in the order of their
importance were: i), the existence of oscillations with
a period close to 24 h; ii), correct phases between various
oscillator components; and iii), reasonable peak/trough ratios
of the mRNA and protein concentrations. The values of the
parameters are listed in Table 1. In the following, the
parameters are given without dimensions for ease of reading.
With the given set of parameters, the clock components
oscillate with a period of 23.8 h, which is a typical period for
mice (Fig. 3 A; Pittendrigh and Daan, 1976). In the model,
the peak/trough ratios for Per2/Cry and Bmal1 mRNA are
5.8 and 7.0, respectively, for nuclear PER2/CRY and
BMAL1 protein we observe peak/trough ratios of 2.4 and
1.7. Experimentally observed peak/trough ratios of mRNA
and protein vary in a wide range from 1.5 to 20, depending
on the tissue and the detection method used (Bunger et al.,
2000; Okamura et al., 1999; Preitner et al., 2002; Shearman
et al., 2000a; Tamaru et al., 2000; Zheng et al., 2001). Most
of our values are consistent with these experimental ﬁndings.
Higher peak/trough ratios as described for PER2 protein in
liver tissue (Lee et al., 2001) are not observed; they might be
due to additional nonlinear processes or higher nonlinearities
in the circadian oscillator, e.g., complex formation with
a higher number of PER2 and CRY proteins (e.g., for q ¼ 4)
TABLE 1 Model parameters
Parameter Value Description
v1b 9 nMh
1 Maximal rate of Per2/Cry transcription
k1b 1 nM Michaelis constant of Per2/Cry
transcription
k1i 0.56 nM Inhibition constant of Per2/Cry
transcription
c 0.01 nM Concentration of constitutive activator
p 8 Hill coefﬁcient of inhibition of Per2/Cry
transcription
k1d 0.12 h
1 Degradation rate of Per2/Cry mRNA
k2b 0.3 nM
1h1 Complex formation rate of PER2/CRY
q 2 No. of PER2/CRY complex forming
subunits
k2d 0.05 h
1 Degradation rate of the cytoplasmatic
PER2/CRY
k2t 0.24 h
1 Nuclear import rate of the PER2/CRY
complex
k3t 0.02 h
1 Nuclear export rate of the PER2/CRY
complex
k3d 0.12 h
1 Degradation rate of the nuclear
PER2/CRY complex
v4b 3.6 nMh
1 Maximal rate of Bmal1 transcription
k4b 2.16 nM Michaelis constant of Bmal1 transcription
r 3 Hill coefﬁcient of activation of Bmal1
transcription
k4d 0.75 h
1 Degradation rate of Bmal1 mRNA
k5b 0.24 h
1 Translation rate of BMAL1
k5d 0.06 h
1 Degradation rate of cytoplasmatic BMAL1
k5t 0.45 h
1 Nuclear import rate of BMAL1
k6t 0.06 h
1 Nuclear export rate of BMAL1
k6d 0.12 h
1 Degradation rate of nuclear BMAL1
k6a 0.09 h
1 Activation rate of nuclear BMAL1
k7a 0.003 h
1 Deactivation rate of nuclear BMAL1*
k7d 0.09 h
1 Degradation rate of nuclear BMAL1*
FIGURE 3 The model shows sustained circadian oscillations with correct
phase relations. (A) Oscillations of clock gene mRNAs and proteins
generated by the model (Fig. 2) with parameters as given in Table 1. Per2/
CrymRNA (y1, red, dashed line), nuclear PER2/CRY protein (y3, red, solid
line), Bmal1mRNA (y4, green, dashed line), activated BMAL1* (y7, green,
solid line, solid circles), and total BMAL1 protein (y5 1 y6 1 y7, green,
solid line) oscillate with a period of 23.8 h. BMAL1 protein oscillates
antiphasic to Per2/Cry mRNA. Nuclear PER2/CRY protein oscillates with
a phase delay of 7.5 h compared to Per2/Cry mRNA. (B) The phases
between the clock components obtained by the model are in good agreement
with experimental data. (Experiment) The circadian times of the maximum
concentrations of Per2 mRNA (light red), nuclear PER2/CRY protein (dark
red), Bmal1mRNA (light green), and total BMAL1 protein (dark green) are
shown, given as the interval in which the highest concentrations were
measured (Reppert and Weaver, 2001; Tamaru et al., 2000). (Model) The
phases between the maximum concentrations of the corresponding
components are determined and translated into circadian times with the
Per2/Cry mRNA peaking at CT7.
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substantially increases the peak/trough ratio (data not
shown). In the model, the peak concentration of BMAL1 is
about the same as the peak concentration of total (nuclear and
cytoplasmatic) PER2/CRY (not shown). Again, this has been
found experimentally (Lee et al., 2001).
Fig. 3 B shows a comparison of the peak phases of clock
components observed in experiments (Reppert and Weaver,
2001; Tamaru et al., 2000) and in the model. All phases in
the model are in agreement with experimental data. In par-
ticular, the delay of several hours between Per2/Cry mRNA
and nuclear PER2/CRY protein is reproduced by the model.
In the model, this delay is due to the small degradation rates
of Per2/Cry mRNA and cytoplasmatic and nuclear PER2/
CRY as well as to a slow transport to the nucleus. Moreover,
the almost antiphasic phase relation between BMAL1 and
Per2/Cry mRNA that is observed experimentally is repro-
duced in our model. This delay at ﬁrst glance does not ﬁt to
the idea of BMAL1 being the activator of Per2/Cry tran-
scription. In our model, the large delay is only possible if
an activated form of BMAL1 exists. Activation may be
achieved by various processes, such as complex formation
with CLOCK (Gekakis et al., 1998) or posttranslational
modiﬁcation (Eide et al., 2002).
The delay between Per2/Cry mRNA and nuclear PER2/
CRY protein is fundamental and cannot be changed con-
siderably without abolishing oscillations in our model. Ex-
treme delays are achieved by variation of k1d (k1d ¼ 0.492;
delay 8.8 circadian hours) and k2t (k2t ¼ 0.6; delay 7.2
circadian hours). In the negative feedback loop, oscillations
occur if ﬁrstly the sum of the delays (Per2/Cry mRNA-
cytoplasmic PER2/CRY complex-nuclear PER2/CRY com-
plex) is above one-quarter of the period (Glass and Mackey,
1988; McDonald, 1989) and secondly if the amplitude of the
inhibitor (nuclear PER2/CRY) is large enough. With a delay
smaller than the observed 7.2 circadian hours (Per2/Cry
mRNA versus nuclear PER2/CRY complex) not enough
Per/Cry mRNA accumulates before the increasing inhibitor
concentration prevents transcription, and the oscillations
dampen. On the other hand, a large delay (.8.8 h) between
Per2/Cry mRNA and nuclear PER2/CRY protein correlates
with lower amplitudes of the inhibitor and thus oscillations
are lost as well.
The delay between BMAL1 protein and Per2/Cry mRNA
as well as the delay between Bmal1 mRNA and BMAL1
protein are less crucial for the system. They can vary from
;3 to 12 circadian hours or from ;3 to 6 circadian hours,
respectively, without loss of oscillations. This wide range of
possible delays is observed if, e.g., all rate parameters in the
positive feedback are multiplied by the same factor. An
increase of these rate parameters reduces the delay between
Bmal1 mRNA and BMAL1 protein and simultaneously
increases the delay between BMAL1 and Per2/Cry mRNA
and vice versa. The range of possible delays is limited
because: 1), with very high rates in the positive feedback
BMAL1 is rapidly degraded, which leads to a complete loss
of oscillations, and 2), with decreasing rates the peak/trough
ratios in the positive feedback become small and ﬁnally
oscillations disappear in the positive feedback.
Rhythmic versus constant activation of
Per2/Cry transcription
To test whether the positive feedback is essential for the
occurrence of oscillations, we compared the dynamics of
the model with and without positive feedback for a given
strength of the negative feedback. This was done by varying
the parameters v4b and c, which reﬂect the maximal tran-
scription rate of Bmal1 and a constant activator concentration
for Per2/Cry transcription, respectively. By varying these
parameters, the relative amount of positive feedback de-
pendent and independent activation of Per2/Cry transcrip-
tion can be controlled.
First, the dynamics of the system was investigated by
varying positive feedback strength for a low ﬁxed activator
concentration c ¼ 0.01 (Fig. 4 A). For v4b below a threshold
of 0.35 the system reaches a steady state indicated by
a stable Per2/CrymRNA concentration, above this threshold
the system oscillates. Thus, a positive feedback of a certain
strength is necessary for oscillations in the case of low acti-
vator concentration. To compare, the concentration of the
constitutive activator c was varied in a system without posi-
tive feedback (v4b ¼ 0) (Fig. 4 C). With a low concentration
of c (,0.02) no oscillations of Per2/Cry mRNA occur,
whereas a high value of c leads to oscillations. Thus, the posi-
tive feedback can be replaced by a constantly expressed acti-
vator to generate oscillations.
In both cases the period is close to 24 h for a wide range of
v4b and c, respectively (Fig. 4, B and D). Only close to the
Hopf bifurcation point, beyond which oscillations cease to
exist, the period shortens in both cases. Therefore, according
to our studies a low maximal transcription rate of Bmal1
(e.g., by mutation) as well as a constant low expression of
activator should decrease the period.
These dynamical changes are consistent with experimental
data from gene knock-out studies. The lack of oscillations for
low Bmal1 transcription and low constant activation in the
model might reﬂect the molecular and behavioral arrhyth-
micity of Bmal1/ mutant mice, which lack a functional
transcriptional activator complex BMAL1/CLOCK (Bunger
et al., 2000). The maintenance of oscillations without
positive feedback but with high concentration of constitutive
activator may correspond to the dynamics observed in Rev-
erba/mutant mice. These mice are behaviorally rhythmic,
and Per2 and Cry mRNAs and proteins are rhythmically
expressed, although Bmal1mRNA and protein are expressed
at a constant high level (Preitner et al., 2002).
To determine how positive feedback and constant ac-
tivation act together, they were varied simultaneously, while
keeping the average concentration of activator (y7 1 c)
constant. Varying the positive feedback strength hardly
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affects the dynamics in the negative feedback. The maximum
and minimum concentrations of Per2/Cry mRNA remain the
same (Fig. 4 E) and the period of the oscillations changes
only slightly (Fig. 4 F). However, for other values of the
parameters of v4b and c the dynamics may change (Fig. 5).
Although a strong positive feedback as well as a high
activator concentration result in oscillations (open area),
attractors coexist for a low concentration of constant
activator c. Oscillations coexist with a stable steady state
for low c and high v4b (shaded area). Here, the dynamics of
the system depends on the initial conditions (insets; see
ﬁgure legend).
Robustness of the system with and without
positive feedback
In several studies, an increase of robustness of the circadian
oscillator has been proposed as a possible function of the
positive feedback (Cheng et al., 2001; Preitner et al., 2002).
Here, we compared the robustness of the system with and
without positive feedback toward parameter changes. All
parameters were varied for a given positive feedback
strength or, alternatively, with a given amount of constantly
expressed activator. For the system including the positive
feedback we use the default parameters (v4b ¼ 3.6 and c ¼
0.01). In the system without positive feedback we assume
v4b ¼ 0 and c ¼ 1 (corresponding to the average amount
of BMAL1* with v4b ¼ 3.6). In both cases, each parameter
was increased or decreased by a factor of two.
The robustness of the systems was investigated with
respect to the existence of oscillations, the period of
oscillations and the phases and amplitudes of the oscillator
components. Oscillations persist in all cases when we change
parameters by a factor of 2. The period and phases (Fig. 6,
A–C) tend to be more robust with respect to parameter
variations than the peak concentrations (Fig. 6, D and E).
This also holds for parameter variations not shown here (see
Supplementary Material). The largest changes of the period
are caused by the variation of degradation and transport rates
in Eqs. 1–3, which form the negative feedback loop (Fig. 6
A, k1d; see Supplementary Material). The inhibitory constant
k1i has a pronounced inﬂuence on the peak concentrations.
The sensitivity of the period, the phases, and the peak
concentrations in the negative loop toward parameter
variation differ only slightly with and without positive
feedback (Fig. 6, A, B, and D), i.e., the positive feedback has
only a minor effect on the negative loop of the oscillator. The
phases and peak concentrations in the positive feedback loop
(Fig. 6, C and E) are somewhat more sensitive toward
parameter variations.
To summarize, the negative feedback loop turns out to be
a robust mechanism, whereas the positive feedback itself is
more sensitive toward parameter variations. This raises the
idea that the negative feedback guarantees undisturbed
circadian oscillations, whereas the easily achieved modula-
tion of the components of the positive feedback provides the
possibility to change the phase and level of clock-dependent
gene transcription.
FIGURE 4 Positive feedback and constant activa-
tion can both lead to oscillations. (A) Per2/Cry mRNA
concentration with varying transcription rate of Bmal1
(v4b). For a low transcription rate of Bmal1, the Per2/
Cry concentration reaches a steady state. In the Hopf
bifurcation point at v4b¼ 0.35 the steady state becomes
unstable; for higher values of v4b the Per2/Cry mRNA
concentration oscillates. Thick lines represent the
maximum and minimum of the oscillation. For
instance, with the default parameter value v4b ¼ 3.6
the Per2/Cry mRNA concentration oscillates between
0.3 and 1.5 nM (see Fig. 3 A). The dashed line marks
the unstable steady state. (C) Per2/Cry mRNA
concentration with varying amount of constantly
expressed activator c. With low levels of activator the
Per2/Cry mRNA concentration reaches a steady state.
An activator concentration above the Hopf bifurcation
point at c ¼ 0.02 results in Per2/Cry mRNA
oscillations. (B andD) Oscillation periods as a function
of Bmal1 transcription rate v4b and constantly ex-
pressed activator c, respectively. In both cases the
period is stable for a broad parameter range and shows
a stronger parameter dependence close to the Hopf
bifurcation point. (E, F) The positive feedback is
gradually replaced by constant activation. The average
amount of total activator (y7peak 1 y7trough)/2 1 c is
kept constant. Zero-percent positive feedback corre-
sponds to v4b ¼ 0 and c ¼ 1; 100% corresponds to v4b
¼ 3.6 and c ¼ 0.01. Oscillations of Per2/Cry mRNA
occur in all cases (E); the period remains stable (F).
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Interplay of positive and negative feedback
As described in the previous section, the strength of the
negative feedback represented by the inhibitory constant k1i
particularly inﬂuences the peak concentration of the
oscillations. Because the nuclear PER2 and CRYs both
regulate the positive and the negative feedback, it is
interesting to study the interdependence of both feedbacks
with respect to the dynamics of the system. To this end, the
strength of the positive and the negative feedback was
changed simultaneously by varying the Bmal1 transcription
rate v4b and the inhibitory constant k1i for various ﬁxed
concentrations of activator c (Fig. 7). Note, that the strength
of the negative feedback falls with rising k1i.
For large values of c, an increasing negative feedback
strength as well as an increasing positive feedback strength
supports oscillations. For smaller values of c, the positive
feedback is still supporting oscillations. Regarding the
negative feedback, however, there exists a limited range of
oscillations. Here, oscillations only occur if the negative
feedback does not exceed an upper and a lower limit. Thus,
for small values of c where the positive feedback is the
dominant source of activation there exists a complex
interplay of positive and negative feedback. Changes in
both the positive and the negative feedback strength are
accompanied by a change of the period: The period is smaller
near the bifurcation line that separates the oscillatory from
the nonoscillatory parameter range. The default parameter
values, which lead to the best consistency of the model
with the experimentally observed oscillatory behavior, are
marked by a solid circle (Figs. 7 B and 8, point 1). For these
parameters, a loss of oscillations due to a decrease in the posi-
tive feedback can be prevented by decreasing negative feed-
back, i.e., an increase of k1i (Fig. 8; see below).
We can relate this observation to well-characterized mouse
mutants. Reppert and colleagues proposed that PER2 pos-
itively regulates Bmal1 transcription as an element of the
positive feedback (Shearman et al., 2000b). Assuming that
PER2 predominantly activates Bmal1 transcription and
CRYs inhibit Per2/Cry transcription, our model can explain
the nonintuitive rhythmic phenotype of the Per2Brdm1/
FIGURE 6 Circadian oscillations are robust toward parameter variations
with respect to period, phases, and amplitudes with and without positive
feedback. Single parameters are varied systematically (Y, divided by 2, open
bars; [, multiplied with 2, solid bars) in the system with (left) and without
(right) positive feedback. As representatives for all parameters (see
Supplementary Material) the variations of v1b (synthesis rate in the negative
loop), k1d (degradation rate in the negative loop), k1i (inhibitory constant),
v4b (synthesis rate in the positive loop), and k4d (degradation rate in the
positive loop) are shown. The relative changes of the period (A), phase
differences (B, C), and peak concentrations (D, E) of the oscillations are
determined: B, phase difference between y1 and y3; C, phase difference
between y4 and y5 1 y6 1 y7; D, peak concentration of y3; E, peak
concentration of y5 1 y6 1 y7. With and without positive feedback the
period only changes signiﬁcantly when k1d is varied. The relative changes of
phase and amplitude are smaller in the negative loop (B, D) than in the
positive loop (C, E).
FIGURE 5 The positive feedback allows coexisting states in the system.
The transcription rate of Bmal1, v4b, and the concentration of the con-
stitutively expressed transcriptional activator, c, are varied simultaneously.
The color of the parameter regions encode different types of dynamical
behavior. In the white area the system shows oscillations; for parameters of
the dark gray area, a stable steady state is reached. Complex dynamics are
observed for low values of c. In that case, oscillations may coexist with a
stable steady state (light gray area). An example of coexisting states is shown
for v4b ¼ 3.6, c ¼ 0.002 (solid circle, insets): The same system (shown
is y1) either oscillates or is in a stable steady state depending on the initial
conditions (initial conditions 1, all variables initialized at 1; initial conditions
2, all variables initialized at 0). For lower v4b, the coexistence of two steady
states (black area) is observed.
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Cry2/ double-mutant mice (Fig. 8). The Per2Brdm1
mutation (functional null mutation) leads to a decrease of
the Bmal1 transcription rate, resulting in a loss of oscillations
(Fig. 8, point 2). For simulation of the Per2Brdm1 mutation,
we assume that PER1 and/or PER3 have some ability to
substitute for PER2 in the PER/CRY complex, so that the af-
fected parameter values remain greater than zero. The sec-
ond mutation Cry2/ is associated with a decrease of the
negative feedback, leading to a rescue of oscillations (Fig. 8,
point 3).
The phases of the oscillations are little inﬂuenced by this
‘‘double mutation’’, whereas the amplitudes are not main-
tained. Interestingly, the period is preserved, when the
positive and negative feedback are decreased simultaneously
(Fig. 7 B). While a decrease of the positive feedback is
accompanied by a shortening of the period, the decrease of
the negative feedback lengthens the period. Similar results
have been obtained in corresponding mutation experiments:
While Per2Brdm1mutant mice have a shortened period before
they get arrhythmic (Zheng et al., 1999), the Cry2/ mutant
mice have a longer period than wild-type mice (van der Horst
et al., 1999; Vitaterna et al., 1999). The period of Per2Brdm1/
Cry2/ double-mutant mice is approximately the same
compared to that of wild-type mice (Oster et al., 2002).
The role of PER2 is probably far more complex than only
being an activator of Bmal1 transcription; e.g., mutation of
the Per2 gene might also affect complex formation with
CRY proteins, thereby inﬂuencing both negative and pos-
itive feedback. Considering this dual role of PER2, the
Per2Brdm1 mutant has been simulated by reducing the rate of
formation of the PER2/CRY complex (k2b). The results of
these simulations are qualitatively similar to those described
above where we only changed the positive feedback for the
Per2Brdm1 mutation. Oscillations disappear in the Per2Brdm1
mutant and reappear in the Per2Brdm1/Cry2/ double
mutant (Fig. 8 B). The rescue of oscillations in the
FIGURE 7 The state of the system depends on the positive and the
negative feedback as well as on the constant activator concentration c. The
dynamics of the system is analyzed for varying strengths of the positive (v4b)
and negative (k1i) feedback with various concentrations of constantly
expressed transcriptional activator c ((A) c ¼ 0.025, (B) c ¼ 0.01, (C) c ¼
0.008, and (D) c ¼ 0; colored area, oscillations; black area, steady state).
Very weak and very strong negative feedback lead to a loss of oscillations.
Stronger positive feedback increases the range of oscillations. High values of
the activator c support oscillations. The color indicates the period of the
oscillations in hours for the reference parameter set and v4b and k1i given in
each point (d, reference values of v4b and k1i as given in Table 1). With rising
v4b the period increases, with rising k1i it either decreases or increases
depending on the position. Note that the strength of the negative feedback
falls with rising k1i.
FIGURE 8 Variations of the strength of positive and negative feedback
lead to dynamical changes observed experimentally in mouse mutants. (A)
Loss-of-function mutations of Per2 and Cry are simulated using the
assumption that PER2 is mainly activating Bmal1 transcription and CRY is
predominantly inhibiting BMAL1/CLOCK transcriptional activity. Com-
pared to the wild-type (wt) mice (point 1, v4b ¼ 3.6, k1i ¼ 0.56) in the
Per2Brdm1 mutant mice v4b is decreased, which leads to a loss of oscillations
(point 2, v4b¼ 0.2, k1i¼ 0.56). The additional mutation of Cry2 is simulated
by an increase of k1i (point 3, v4b ¼ 0.2, k1i ¼ 1.5), i.e., a decrease of the
strength of the negative feedback. This leads to a rescue of oscillations, as
seen in the Per2Brdm1/Cry2/ double mutant (Oster et al., 2002). Axis units
of the insets are as in Fig 3 A. (B) To account for a possible role of PER2 in
the negative feedback, the Per2Brdm1 mutant is modeled by a decrease of the
complex formation rather than by a decrease of the positive feedback
strength v4b (wt, point 1, k2b ¼ 0.3, k1i ¼ 0.56). Again, the Per2Brdm1
mutation leads to a loss of oscillations (point 2, k2b ¼ 0.005, k1i ¼ 0.56),
which is rescued by the simultaneous Cry2/ mutation (point 3, k2b ¼
0.005, k1i ¼ 1).
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Per2Brdm1/Cry2/ double mutant is also observed, if, in
addition to its function in the positive feedback, PER2
inhibits Per2/Cry transcription to a low extent (i.e., v4b is
decreased and k1i is increased in the Per2
Brdm1mutation; e.g.,
shift of point 2 in Fig. 8 A to k1i ¼ 0.7). In the case of PER2
being a stronger inhibitor of Per2/Cry transcription, the
negative feedback would be largely decreased in the
Per2Brdm1 mutation, and the loss of oscillations (e.g., v4b ¼
0.2; k1i ¼ 80) could not be rescued by a further decrease of
the negative feedback. Therefore, our simulations only
account for the oscillations in the Per2Brdm1/Cry2/ double
mutant if we assume the direct inhibition of Per2/Cry
transcription by PER2 to be weak. Experiments indeed
suggest that PER2 is a rather weak inhibitor compared to
CRY1 and CRY2 (Grifﬁn et al., 1999).
The period of the Cry1/mutant mice is shorter than that
of wild-type mice (van der Horst et al., 1999, Vitaterna et al.,
1999) and this mutation cannot rescue the oscillations in the
Per2Brdm1 mice (Oster et al., 2002). The functional
difference between the homologs is not known; however,
a difference in the inhibitory strength is discussed, CRY1
being the stronger inhibitor (Grifﬁn et al., 1999). Under this
assumption, the negative feedback in the Cry1/ mutant is
weaker than in the Cry2/ mutant. In our model, the period
changes for varying negative feedback strength are indeed
nontrivial (Fig. 7 B): Depending on howmuch the strength of
the negative feedback is reduced, the period can either
become longer or shorter than under default conditions.
Close to the default conditions the period increases with
decreasing negative feedback (i.e., rising k1i, corresponding
to the Cry2/ mutation). A further decrease of the negative
feedback leads to a shortening of the period (k1i . 1.5). A
decrease under a certain threshold (k1i . 60) fails to rescue
the oscillations in the case of a weak positive feedback (v4b¼
0.2). This parameter setting (k1i . 60) might reﬂect the state
observed in the Cry1/ mutant: This mutation leads to
a short period in a wild-type background (v4b ¼ 3.6), and it
fails to rescue oscillations in Per2Brdm1 mice (v4b ¼ 0.2).
Thus, the persisting arrhythmicity of Per2Brdm1/Cry1/
mutant mice (Oster et al., 2002) can be reproduced by the
model. For a very weak negative feedback (k1i . 756.8) the
oscillations disappear (not depicted in the ﬁgure) even for a
positive feedback strength corresponding to wild type (v4b ¼
3.6). This is consistent with the loss of rhythmicity in the
Cry1//Cry2/ double mutant (van der Horst et al., 1999).
Taking these considerations together this leads us to
a testable prediction. In our model, a loss of oscillations due
to a decrease of the positive feedback can be rescued by an
increase of the constant activator concentration c (e.g., Fig. 7
A; c ¼ 0.025). A high activator concentration c also supports
oscillations if k2b instead of v4b is decreased (c . 0.073 for
k2b ¼ 0.005, k1i ¼ 0.56, v4b ¼ 3.6 as in Fig. 8 B, not shown).
In Rev-erba/ mutant mice the BMAL1 concentration is
constantly high, which may be reﬂected by a high value of
c in the model. Therefore, independent of the model re-
presentation of the Per2Brdm1 mutation, our model predicts
that the simultaneous mutation of the Rev-erba gene should
prevent the loss of oscillations in Per2Brdm1 mutant mice.
DISCUSSION
With the quickly expanding knowledge about the circadian
oscillator our view of the clock is getting more and more
complex. The model presented here is designed to describe
the basic structure of the oscillator, focusing on positive and
negative feedback loops. Although a detailed model is useful
for examining elementary molecular processes of the
mammalian clock (Forger and Peskin, 2003; Leloup and
Goldbeter, 2003), for the investigation of the positive
feedback a reduced model as presented here is more ap-
propriate. A lower number of variables and parameters is
achieved by lumping various variables and by using
primarily linear kinetics where appropriate. This facilitates
the investigation and understanding of the dynamics. The dy-
namics of the resulting model is in accordance with ex-
perimental data regarding period, phase relations, and peak/
trough ratios of the oscillating components.
A motivation of this study was to explore possible
functions of the positive feedback within the circadian core
oscillator. It turned out that the negative feedback is
sufﬁcient for the occurrence of oscillations, i.e., the positive
feedback can be replaced by a constantly expressed activator.
Similar results have been found in a model for the
Drosophila oscillator that is based on delay differential
equations (Smolen et al., 2002). This ﬁnding suggests that
the loss of oscillations in Bmal1/ mutant mice is due to
a lack of transcriptional activator rather than a lack of the
positive feedback. This idea is supported by the phenotype of
Rev-erba/ mutant mice, in which the activator BMAL1 is
expressed at a constant high level. These mice are
behaviorally rhythmic although they lack a functional
positive feedback. The Rev-erba/mice provide an optimal
tool to test whether the regulation of output processes (other
than locomotor activity) is a function of the positive feed-
back. If this is the case, at least some circadianly regulated
processes should lose their rhythmicity in the Rev-erba/
mice, as those mice lack oscillations of BMAL1. A loss of
oscillations for an increased Bmal1 transcription rate as
described in a detailed model by Leloup and Goldbeter
(2003) has not been observed in our model.
Does the positive feedback inﬂuence the robustness of the
circadian oscillator? It turned out that with and without
positive feedback the oscillations of components in the
negative feedback loop are quite robust. In contrast, compo-
nents of the positive feedback loop itself are more sensitive
toward parameter variations. This is interesting in the context
that the positive feedback and the resulting BMAL1 oscil-
lations might be used to regulate output processes. The
higher variability of phases and peak concentrations in the
positive feedback principally allows to modulate output
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pathways without disturbing circadian oscillations. Varia-
tions of parameters such as synthesis rates in the positive
feedback loop will hardly affect the basic core oscillation,
but change the phase and strength of gene expression
regulated by components of the positive feedback loop. The
period of the oscillations is little affected by changes in the
positive feedback.
Positive and negative feedback are not independent from
each other. The inhibition of BMAL1/CLOCK by PER and
CRY proteins affects both the positive and the negative
feedback, because BMAL1/CLOCK activates transcription
of Per, Cry, and Rev-erba genes via binding to E-box
elements in their promoters (Fig. 1; Gekakis et al., 1998).
Any change of the conditions in the cell that inﬂuences the
inhibitory strength of PER and CRY proteins on BMAL1/
CLOCK therefore leads to simultaneous changes in the
positive and the negative feedback. In the model, this cor-
responds to a coordinated change of v4b and k1i in opposite
directions. Compared to a single parameter variation of v4b or
k1i the oscillations are maintained for a wider range of v4b
and k1i if the parameters are varied simultaneously (Fig. 7 B).
The coregulation of positive and negative feedback by PER
and CRY proteins, therefore, increases the stability of
oscillations toward environmental changes, such as redox
potential, nutrient conditions, or metabolic state of the cell
(Rutter et al., 2002).
Although a role of PERs and CRYs in the circadian core
oscillator is generally accepted, the exact molecular function
of these proteins is not fully understood. In the arrhythmic
Cry1//Cry2/ double-mutant mice Per2 mRNA is
expressed at a rather high constant level, supporting a role
of CRY proteins in the negative feedback (Okamura et al.,
1999). In contrast, in Per2Brdm1 mutant mice (loss-of-
function mutation) the mRNA concentrations of Bmal1 and
Cry1 are severely blunted. This led to the proposal that PER2
positively acts on Bmal1 transcription and is therefore a
player in the positive feedback loop (Shearman et al., 2000b).
Although PER2 and CRY proteins are represented by
a lumped variable in our model, these considerations allow us
to simulate the effect of mutations in those clock genes using
parameter variations. Themutations aremodeled by changing
the features of the lumped variable. The mutation of Per2 is
reﬂected by a decrease of the activating strength of the com-
plex, whereas the mutation of Cry1 or Cry2 is modeled by
a decrease of the inhibitory strength to different extents.
Interestingly, in the arrhythmic Per2Brdm1 mutant mice
molecular and behavioral oscillations can be rescued with an
additional loss-of-function mutation for Cry2 (Oster et al.,
2002). This can be explained by our model (see Fig. 8). A
decrease of the positive feedback (Per2Brdm1) leads to a loss
of oscillations. This is compensated by a simultaneous
decrease of the negative feedback (Cry2/) resulting in the
preservation of oscillations. By knocking outCry1 rather than
Cry2 in a Per2Brdm1 background, oscillations are not rescued
(Oster et al., 2002). Although a moderate increase of k1i
representing a Cry2 mutation lengthens the period, a shorter
period is observed with a strong increase of k1i representing
the Cry1 mutation. A difference in the inhibitory strength of
the two homologs, therefore, can explain the experimentally
observed opposite effect of the mutations on the period.
The function of PER2 is probably more complex than
exclusively activating Bmal1 transcription. It forms a com-
plex with CRY proteins (Lee et al., 2001) and thus might
play a role in the inhibition of BMAL1/CLOCK (Kume et al.,
1999). In our model, however, this role does not seem to be
responsible for the loss of oscillations in the Per2Brdm1
mutant, as a moderate decrease of the negative feedback
strength rather supports oscillations than prevents them
(Figs. 7 and 8). The loss of oscillations in the Per2Brdm1
mutant, therefore, seems to be due to the changes in the
positive feedback strength.
For PER2 being a player in the positive feedback loop we
can make the following prediction: oscillations in the
arrhythmic Per2Brdm1 mutant mice should be rescued by an
additional loss-of-function mutation for Rev-erba. This can
be tested by crossing Rev-erba/ and Per2Brdm1 mutant
mice. In the resulting double-mutant mice a constant high
expression of BMAL1 due to the mutation of Rev-erba
should replace the positive feedback. In the model, the Rev-
erba/ mutant is described by a high concentration of
constitutive activator c, which replaces the positive feed-
back-dependent Bmal1 transcription rate (v4b ¼0). Therefore
the additional mutation of Per2, which is simulated by a
decrease of v4b, has no further effect and the oscillations are
maintained. Consequently, we predict a rhythmic behavior
of those double-mutant mice.
Another important clock gene, Per1, is not explicitly
included in the model, because its speciﬁc role within the
positive or negative feedback loop (in contrast to its function
in response to light) is not well understood. As soon as more
data accumulate, the role of Per1 can in principle be in-
vestigated by varying parameters of the model, as it has
been done for differentiating the functions of Cry1, Cry2,
and Per2 (Fig. 8).
A characteristic feature of the circadian oscillator is
temperature compensation, which guarantees a remarkably
stable circadian period over a wide temperature range
(Zimmerman et al., 1968). Temperature compensation of
circadian oscillators has been addressed in models, assuming
either a varying (Ruoff and Rensing, 1996) or the same
sensitivity (Leloup and Goldbeter, 1997) of all parameters
toward temperature changes. The crucial condition for the
ﬁrst method is the existence of parameters that when changed
have the opposite effect on the period. As this condition is
fulﬁlled in our model (Fig. 6 A), temperature compensation
can be achieved with the method of Ruoff and Rensing
(1996).
In our study, we focus on oscillations generated in a single
cell. Although the circadian oscillation in the suprachias-
matic nucleus is generated at the level of individual neurons
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(Welsh et al., 1995), under natural conditions the cells
interact and thereby form whole networks of coupled oscil-
lators. Additional dynamic phenomena can be expected from
this more complex system. A molecular model as presented
here is a good tool to approach questions of coupling and
synchronization, as has been done before for ultradian
cellular rhythms (Ho¨fer, 1999; Wolf and Heinrich, 2000) and
for a nonmolecular model of the circadian clock (Kunz and
Achermann, 2003).
In summary, our model describes well the molecular
rhythms observed in the neurons of the suprachiasmatic nu-
cleus and their associated behavioral rhythms. Focusing on
modules like negative or positive feedback loops within the
transcriptional/translational regulatory network helped to
dissect their differential roles in this system. The speciﬁc
design of the model, taking into account only essential
processes, should make it a valuable tool for various addi-
tional studies including: i), the entrainment of the oscillator
to light-dark cycles (appropriate phase response curves are
obtained when ‘‘gating’’ is included; Geier et al., 2004); ii),
the incorporation of putative novel components or mech-
anisms (Becker-Weimann et al., 2004); iii), stochastic
simulations for investigating the inﬂuence of molecular
noise on circadian oscillations (Gonze et al., 2002); iv),
output processes for the expression of different phases; v),
the coupling of oscillators for the simulation of synchroni-
zation events within the suprachiasmatic nuclei as well as
between the clock in the brain and in peripheral tissues; and
vi), temperature compensation.
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